These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19237274)

  • 1. GHB in Sydney, Australia, 2000-2006: a case study of the EDRS as a strategic early warning system.
    Dunn M; Topp L; Degenhardt L
    Int J Drug Policy; 2009 Sep; 20(5):413-7. PubMed ID: 19237274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2006 Sep; 25(5):445-9. PubMed ID: 16939940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of GHB and ketamine use in an Australian household survey.
    Degenhardt L; Dunn M
    Int J Drug Policy; 2008 Aug; 19(4):311-6. PubMed ID: 17920826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of drug detection dogs in Sydney, Australia.
    Dunn M; Degenhardt L
    Drug Alcohol Rev; 2009 Nov; 28(6):658-62. PubMed ID: 19930020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system.
    Topp L; Degenhardt L; Kaye S; Darke S
    Drug Alcohol Rev; 2002 Dec; 21(4):341-8. PubMed ID: 12537703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia.
    Burns L; Roxburgh A; Bruno R; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):840-5. PubMed ID: 24574080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging psychoactive substance use among regular ecstasy users in Australia.
    Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
    Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'.
    Topp L; Breen C; Kaye S; Darke S
    Drug Alcohol Depend; 2004 Feb; 73(2):189-97. PubMed ID: 14725959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
    Giraudon I; Bello PY
    Subst Use Misuse; 2007; 42(10):1567-78. PubMed ID: 17918027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
    Brennan R; Van Hout MC
    J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monitoring of drug trends in Australia.
    Shand F; Topp L; Darke S; Makkai T; Griffiths P
    Drug Alcohol Rev; 2003 Mar; 22(1):61-72. PubMed ID: 12745360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
    Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
    Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From alcohol to liquid ecstasy (GHB)--a survey of old and modern knockout agents. Part 3: gamma-hydroxybutyric acid ("liquid ecstasy")].
    Schütz H; Jansen M; Verhoff MA
    Arch Kriminol; 2011; 228(5-6):151-9. PubMed ID: 22276366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GHB--dangerous, addictive and uncontrollable "party drug"].
    Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
    Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.
    Anderson IB; Kim SY; Dyer JE; Burkhardt CB; Iknoian JC; Walsh MJ; Blanc PD
    Ann Emerg Med; 2006 Feb; 47(2):177-83. PubMed ID: 16431231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mortality rates among GHB abusers in Western Sweden.
    Knudsen K; Greter J; Verdicchio M
    Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earlier warning: a multi-indicator approach to monitoring trends in the illicit use of medicines.
    Mounteney J; Haugland S
    Int J Drug Policy; 2009 Mar; 20(2):161-9. PubMed ID: 18032012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.